Related references
Note: Only part of the references are listed.Modelling formulations using gene expression programming - A comparative analysis with artificial neural networks
E. A. Colbourn et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2011)
A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment
Xiaoming Xu et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)
What are artificial neural networks?
Anders Krogh
NATURE BIOTECHNOLOGY (2008)
Pharmaceutical quality by design: Product and process development, understanding, and control
Lawrence X. Yu
PHARMACEUTICAL RESEARCH (2008)
PQLI Key Topics - Criticality, Design Space, and Control Strategy
Thomas Garcia et al.
Journal of Pharmaceutical Innovation (2008)
Investigation of an artificial intelligence technology - Model trees - Novel applications for an immediate release tablet formulation database
Q. Shao et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2007)
Process control perspective for process analytical technology: Integration of chemical engineering practice into semiconductor and pharmaceutical industries
Huiquan Wu et al.
CHEMICAL ENGINEERING COMMUNICATIONS (2007)
Comparison of neurofuzzy logic and neural networks in modelling experimental data of an immediate release tablet formulation
Qun Shao et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
Optimization of neural network architecture using genetic programming improves detection and modeling of gene-gene interactions in studies of human diseases
MD Ritchie et al.
BMC BIOINFORMATICS (2003)
Basic concepts of artificial neural network (ANN) modeling and its application in pharmaceutical research
S Agatonovic-Kustrin et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2000)
Share Paper
